Application of sphingolipid-based nanocarriers in drug delivery: an overview
- 29 July 2024
- journal article
- review article
- Published by Taylor & Francis in Therapeutic Delivery
- Vol. 15 (8) , 619-637
Abstract
Sphingolipids (SL) are well recognized for their cell signaling through extracellular and intracellular pathways. Based on chemistry different types of SL are biosynthesized in mammalian cells and have specific function in cellular activity. SL has an ampiphilic structure with have hydrophobic body attached to the polar head enables their use as a drug delivery agent in the form of nanocarriers. SL-based liposomes can improve the solubility of lipophilic drugs through host and drug complexes and are more stable than conventional liposomal formulations. Preclinical studies of SL nanocarriers are reported on topical delivery, oral delivery, ocular delivery, chemotherapeutic delivery, cardiovascular delivery and Alzheimer's disease. The commercial challenges and patents related to SL nanoformulations are highlighted in this article.Keywords
This publication has 103 references indexed in Scilit:
- Linking glycosphingolipids to Alzheimer’s amyloid-ß: extracellular vesicles and functional plant materialsGlycoconjugate Journal, 2022
- Ceramide function in the brain: when a slight tilt is enoughCellular and Molecular Life Sciences, 2012
- Topical emulsions containing ceramides: Effects on the skin barrier function and anti‐inflammatory propertiesEuropean Journal of Lipid Science and Technology, 2011
- An Overview of Sphingolipid Metabolism: From Synthesis to Breakdown2010
- Use of a novel anti-proliferative compound coated on a biopolymer to mitigate platelet-derived growth factor-induced proliferation in human aortic smooth muscle cells: comparison with sirolimusGlycoconjugate Journal, 2008
- Roles of Bioactive Sphingolipids in Cancer Biology and Therapeutics2008
- Mitochondrial Ceramide and the Induction of ApoptosisJournal of Bioenergetics and Biomembranes, 2005
- Long Circulating Liposome Therapeutics: From Concept to Clinical Reality1998
- Cell regulation by sphingosine and more complex sphingolipidsJournal of Bioenergetics and Biomembranes, 1991
- Modulation of cell surface iron transferrin receptors by cellular density and state of activationJournal of Supramolecular Structure, 1979